Chester County News and Community Website
NEW HOPE, PA — A galaxy far, far away is landing right in Bucks County as New Hope transforms into an immersive, town-wide Star Wars celebration spanning four days of …
New Hope Turns Into a Star Wars Playground for Four-Day May the 4th Celebration Read More
NEWTOWN, PA — The Alloy Market launched a resale marketplace for authenticated estate and fine jewelry, introducing a model that allows items to be resold rather than melted to increase …
Alloy Market Launches Jewelry Resale Platform With Profit-Sharing Program Read More
WASHINGTON CROSSING, PA — American Pharmacy Cooperative, Inc. (APCI) is expanding its social media strategy through a partnership with Baldwin Publishing to help independent pharmacies increase visibility and compete with …
APCI Expands Social Media Strategy for Independent Pharmacies Read More
NEWTOWN, PA — Catalyx has entered a partnership with Canoga Perkins to integrate private 5G Time Sensitive Networking technology into its OpenLine LineClearance Assistant 3.0 platform to improve manufacturing efficiency …
Catalyx Partners With Canoga Perkins on 5G Manufacturing Technology Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) will present early results from a Phase 1 clinical trial of its WEE1 inhibitor APR-1051 at the 2026 American Society of Clinical …
Aprea Abstract Accepted for ASCO on APR-1051 Phase 1 Study Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) recently closed its previously announced license and acquisition of a portfolio of regenerative biomaterial products from Celularity Inc. (NASDAQ: CELU) and launched a …
NEXGEL Closes Celularity Asset Deal, Launches BioNX Surgical Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) recently granted equity inducement awards to 24 newly hired employees on April 14, 2026, under its 2021 Inducement Equity Incentive Plan.
Savara Grants Equity Awards to 24 New Employees Read More LANGHORNE, PA — The U.S. Food and Drug Administration has extended the review period for Savara Inc.’s (Nasdaq: SVRA) biologics license application for molgramostim by three months, setting a new …
FDA Extends Review of Savara’s Molgramostim Application to November Read More YARDLEY, PA — Acumetis, a life sciences commercialization company formed by combining five consultancies, launched April 14, 2026, to provide integrated services across the biopharmaceutical product lifecycle, the company announced.
Acumetis Launches as Combined Life Sciences Consulting Firm Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) will present new clinical data on its investigational therapy molgramostim at the ATS International Conference in Orlando, Florida, May 17–20, 2026, the company …
Savara to Present Molgramostim Data at ATS 2026 Conference Read More